C/O DENNIS M. LANFEAR, REDWOOD CITY, CA
Financial Results, Press Release
Coherus Oncology Enters Underwriting Agreement for 28.6 Million Shares
Other Events
Coherus Oncology Files Prospectus Supplement for $64.88M Common Stock Offering
Investor Presentation
Cautionary Statement Regarding Forward-Looking Statements
Reports Third Quarter 2025 Financial Results and Provides Business Update
FY 2025
Q3
Q2
Q1
FY 2024
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities to be Offered to Employees
SC TO-I
Definitive Proxy Statement
Additional Proxy Materials
Definitive Merger Proxy Statement
Amended Schedule 13G - Ownership Report
Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Amended Tender Offer Statement by Issuer
PREM14A
Submission Upload
Correspondence